Search results

Selected filters:

Litigation
United Kingdom

Article type

Topic

Sector

116 results found for your search

Sort options
05 April 2019

UK Supreme Court confirms dosage regimens are patentable

Judges rule that inventions arrived at by well-established or routine tests can be patented, but the decision will also reassure generics

29 March 2019

CJEU rules out SPCs for new drug formulations, but leaves uncertainty over therapeutic uses

Following the court’s Abraxis decision, life sciences face a more restrictive interpretation of which products qualify for supplementary protection certificates.

08 March 2019

CJEU asked to resolve long-standing SPC marketing authorisation conundrum

Europe’s highest court has never ruled on whether certificates can be acquired on the basis of a third-party marketing approval – a practice that has given rise to disputes between biopharma innovators

30 January 2019

<em>Arrow</em> declarations: exploiting court flexibility to clear a path to market

When it comes to litigation strategy, drug businesses have another option to consider in some cases thanks to recent rulings from the courts of England and Wales.

24 January 2019

How <em>Arrow</em> declarations can target a clear path to market 

Given the difficulty that pharmaceutical products face when it comes to reaching market, Arrow declarations can be a crucial means of slicing through the knot.

30 November 2018

How a Chinese court would have decided the <em>Unwired Planet</em> appeal

Previous FRAND-related rulings indicate judges in China could set a global rate, would adopt the hard-edged non-discrimination obligation and would consider the parties' negotiation behaviours when reaching their decisions 

29 November 2018

OPINION: It's time to sort out the connected car disconnect

TCL v Ericsson and Unwired Planet v Huawei send two very different messages to auto companies being approached by patent pools such as Avanci to take SEP licences, says Unified Patents' chief IP counsel Jonathan Stroud 

22 November 2018

Second medical use patents on life support in the UK after Supreme Court pregabalin decision

The landmark judgment makes it harder for pharmaceutical companies to use what has become an important source of protection – so opening the way for more generic competition

19 November 2018

Dosage patents come under scrutiny at UK Supreme Court

Justices today considering a much-anticipated case whose outcome could make it harder for pharma companies to obtain such protection in the future

14 November 2018

UK Supreme Court rejects Warner-Lambert’s pregabalin appeal

Company now faces possibility of £500 million pay-out to the NHS, while ruling could also make second medical use patents harder to obtain and easier to invalidate

05 November 2018

European SPC ruling is a blow for medical device innovators

Court of Justice delivers decision that will make it harder for inventors of device-drug combination products to obtain patent term extensions

30 October 2018

What every SEP owner and licensee needs to know about the <em>Unwired Planet</em> decision

In upholding the first instance judgment of Mr Justice Birss last week, the Court of Appeals in London has confirmed the UK as a go-to jurisdiction for FRAND-related disputes

23 October 2018

Court of Appeals in London upholds <em>Unwired Planet v Huawei</em> to provide big boost to SEP holders globally 

Decision to confirm the original Birss judgment is likely to ensure that the UK becomes a major centre for the resolution of FRAND-related disputes

09 October 2018

UK judge reins in ZTE’s China counter-suit against Conversant

But IAM research shows the NPE led by Boris Teksler is facing a barrage of Chinese invalidity actions from both ZTE and its co-defendant Huawei.

13 July 2018

BT assertion against Fortinet shows how cyber security is becoming big patent business

Rare court action from giant telco is further sign of growing monetisation activity in one of hottest areas in tech.